Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
98%
OVERLAP
BY WEIGHT
301
# OF OVERLAPPING
HOLDINGS
FHLC
349
HOLDINGS
96%
ALSO IN VHT
VHT
417
HOLDINGS
78%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus VHT)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in VHT |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 14.6% | 14.7% | 14.6% | |
| JOHNSON & JOHNSON | 8.5% | 8.4% | 8.4% | |
| ABBVIE INC | 6.7% | 6.7% | 6.7% | |
| MERCK & CO. INC. | 4.8% | 4.8% | 4.8% | |
| UNITEDHEALTH GROUP INC | 4.8% | 4.8% | 4.8% | |
FHLC Overweight Relative to VHT
| ROYALTY PHARMA PLC CLASS A | 0.4% | |
| JOHNSON & JOHNSON | 0.1% | |
| CRISPR THERAPEUTICS AG | 0.1% | |
| XENON PHARMACEUTICALS INC | 0.0% | |
| ELEVANCE HEALTH INC | 0.0% | |
| ABSCI CORPORATION | 0.0% | |
| ETON PHARMACEUTICALS, INC. | 0.0% | |
| XERIS PHARMACEUTICALS INC | 0.0% | |
| VERADERMICS INC | 0.0% | |
| REPLIGEN CORP | 0.0% |
FHLC Underweight Relative to VHT
| ELI LILLY & CO | -0.1% | |
| ABBVIE INC | 0.0% | |
| GALENA BIOPHARMA INC | 0.0% | |
| BIOLIFE SOLUTIONS, INC. | 0.0% | |
| UNITEDHEALTH GROUP INC | 0.0% | |
| MERCK & CO. INC. | 0.0% | |
| MANNKIND CORP | 0.0% | |
| REPLIMUNE GROUP, INC. | 0.0% | |
| ABBOTT LABORATORIES | 0.0% | |
| AMGEN INC | 0.0% |